Virtus ETF Advisers LLC Keros Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$183 Million
Q1 2024

A detailed history of Virtus ETF Advisers LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,567 shares of KROS stock, worth $117,311. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,567

Previous 2,743 6.42%

Holding current value

$117,311

Previous $109,000 55.05%

% of portfolio

0.09%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$41.26 - $70.48 $7,261 - $12,404	-176 Reduced 6.42%	2,567 $169,000
Q4 2023 Feb 15, 2024	BUY	$27.12 - $41.05 $4,935 - $7,471	182 Added 7.11%	2,743 $109,000
Q3 2023 Nov 07, 2023	SELL	$31.57 - $43.02 $8,113 - $11,056	-257 Reduced 9.12%	2,561 $81,000
Q2 2023 Aug 14, 2023	BUY	$37.26 - $51.01 $29,845 - $40,859	801 Added 39.71%	2,818 $113,000
Q1 2023 May 15, 2023	SELL	$41.44 - $59.32 $31,950 - $45,735	-771 Reduced 27.65%	2,017 $86,000

Q4 2022 Feb 14, 2023	SELL	$39.45 - $51.77 $40,909 - $53,685	-1,037 Reduced 27.11%	2,788 $133,000
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $889 - $1,283	32 Added 0.84%	3,825 $144,000
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $14,785 - $38,078	568 Added 17.61%	3,793 $105,000
Q1 2022 May 16, 2022	SELL	$42.12 - $59.36 $8,044 - $11,337	-191 Reduced 5.59%	3,225 $175,000
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $22,170 - $37,734	-600 Reduced 14.94%	3,416 $200,000
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $6,234 - $9,310	-213 Reduced 5.04%	4,016 $159,000
Q2 2021 Aug 10, 2021	BUY	$42.4 - $70.11 $16,705 - $27,623	394 Added 10.27%	4,229 $180,000
Q1 2021 May 17, 2021	BUY	$54.0 - $75.28 $4,158 - $5,796	77 Added 2.05%	3,835 $236,000
Q4 2020 Feb 12, 2021	BUY	$36.0 - $82.74 $135,288 - $310,936	3,758 New	3,758 $265,000

Others Institutions Holding KROS

# of Institutions

153

Shares Held

26.7M

Call Options Held

47.6K

Put Options Held

34.5K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Keros Therapeutics, Inc. Transaction History